Katsuhiro Shono

发表

A Prospective, Longitudinal Observation of the Incidence, Treatment, and Survival of Late Acute and Chronic Graft-versus-host disease by National Institutes of Health Criteria in a Japanese cohort.

H. Nakasone, Y. Kanda, Jun Kato, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

D816 mutation of the KIT gene in core binding factor acute myeloid leukemia is associated with poorer prognosis than other KIT gene mutations

J. Kanda, K. Inokuchi, S. Chiba, 2017, Annals of Hematology.

Efficacy and tolerability of rituximab and reduced-dose cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy for elderly patient with diffuse large B-cell lymphoma

Katsuhiro Shono, A. Yokota, M. Onoda, 2018, Hematology.

Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia

J. Kanda, S. Kako, Y. Kanda, 2021, Blood advances.

Reduced-intensity conditioning is a reasonable alternative for Philadelphia chromosome-positive acute lymphoblastic leukemia among elderly patients who have achieved negative minimal residual disease: a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSHCT

S. Kako, Y. Kanda, Y. Najima, 2020, Bone Marrow Transplantation.

NPM1-mutation-based measurable residual disease assessment after completion of two courses of post-remission therapy is a valuable clinical predictor of the prognosis of acute myeloid leukemia

J. Kanda, S. Kako, Y. Kanda, 2022, International Journal of Hematology.

Pharmacokinetically guided, once-daily intravenous busulfan in combination with fludarabine for elderly AML/MDS patients as a conditioning regimen for allogeneic stem cell transplantation

C. Nakaseko, T. Muto, N. Mimura, 2021, International Journal of Hematology.

Allogeneic hematopoietic stem cell transplantation for aplastic anemia with pre‐transplant conditioning using fludarabine, reduced‐dose cyclophosphamide, and low‐dose thymoglobulin: A KSGCT prospective study

S. Kako, Y. Kanda, Jun Kato, 2019, American journal of hematology.

Outcomes of poor peripheral blood stem cell mobilizers with multiple myeloma at the first mobilization: A multicenter retrospective study in Japan

N. Tsukada, M. Matsumoto, Kazuhito Suzuki, 2022, EJHaem.

Impact of standard-dose dipeptidyl peptidase-4 inhibitors on the incidence of graft-versus-host disease after allogeneic hematopoietic cell transplantation

H. Nakasone, S. Kimura, Y. Kanda, 2022, Bone Marrow Transplantation.

Prognostic impact of low allelic ratio FLT3-ITD and NPM1 mutation in acute myeloid leukemia.

J. Kanda, S. Kako, Y. Kanda, 2018, Blood advances.

Acute myelogenous leukemia with Leptotrichia trevisanii bacteremia.

T. Terano, J. Kumagai, Katsuhiro Shono, 2013, Internal medicine.

Pharmacokinetics of intravenous busulfan as condition for hematopoietic stem cell transplantation: comparison between combinations with cyclophosphamide and fludarabine

M. Onizuka, Takehiko Mori, Y. Koda, 2020, International Journal of Hematology.

The occurrence of second neoplasms after treatment with tyrosine kinase inhibitors for chronic myeloid leukemia

Katsuhiro Shono, A. Yokota, M. Onoda, 2014, Leukemia & lymphoma.

Efficacy and safety of oral deferasirox treatment for transfusional iron overload in pure red cell aplasia patients after allogeneic stem cell transplantation

C. Nakaseko, M. Onizuka, Satoshi Takahashi, 2019, Annals of Hematology.

Prognostic index for patients with relapsed or refractory acute myeloid leukemia who underwent hematopoietic cell transplantation: a KSGCT multicenter analysis

S. Fujiwara, S. Kimura, J. Kanda, 2019, Leukemia.

Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia with Pre-Transplant Conditioning Using Fludarabine, Reduced-Dose Cyclophosphamide, and Low-Dose Thymoglobulin:Â Ksgct Prospective Study

S. Kako, Y. Kanda, M. Onizuka, 2018, Blood.

Prognostic impact of serum soluble LR11 in newly diagnosed diffuse large B-cell lymphoma: A multicenter prospective analysis.

Hiroyuki Ebinuma, K. Yokote, C. Nakaseko, 2016, Clinica chimica acta; international journal of clinical chemistry.

Pre-conditioning intervention in patients with relapsed or refractory acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation: a KSGCT multicenter retrospective analysis

S. Fujiwara, S. Kimura, J. Kanda, 2021, Annals of Hematology.

The sensitivity of the FLT3-ITD detection method is an important consideration when diagnosing acute myeloid leukemia

K. Ohashi, K. Inokuchi, Y. Najima, 2020, Leukemia research reports.

Resignation and return to work in patients receiving allogeneic hematopoietic cell transplantation close up

S. Fujiwara, Takuhiro Yamaguchi, S. Kato, 2021, Journal of Cancer Survivorship.

Autoimmune thyroid dysfunction after allogeneic hematopoietic stem cell transplant

Katsuhiro Shono, A. Yokota, M. Onoda, 2016, Leukemia & lymphoma.

Decision Analysis of Postremission Therapy in Cytogenetically Intermediate-Risk Acute Myeloid Leukemia: The Impact of FLT3 Internal Tandem Duplication, Nucleophosmin, and CCAAT/Enhancer Binding Protein Alpha.

J. Kanda, Takuhiro Yamaguchi, K. Inokuchi, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcomes and prognostic factors for patients with relapsed or refractory acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation: a KSGCT multicenter analysis.

S. Fujiwara, S. Kimura, J. Kanda, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical benefits of pre-conditioning intervention in patients with relapsed or refractory acute myeloid leukemia who underwent allogeneic hematopoietic cell transplantation: a KSGCT multicenter analysis.

S. Fujiwara, S. Kimura, J. Kanda, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

MYC/BCL2 Double-hit Lymphoma in a Patient with Rheumatoid Arthritis Associated with Methotrexate Treatment.

Katsuhiro Shono, A. Yokota, R. Kurimoto, 2016, Internal medicine.

Significance of FLT3-tyrosine kinase domain mutation as a prognostic factor for acute myeloid leukemia

J. Kanda, S. Kako, Y. Kanda, 2019, International Journal of Hematology.

Mutational analysis of DNMT3A improves the prognostic stratification of patients with acute myeloid leukemia

J. Kanda, S. Kako, Y. Kanda, 2023, Cancer science.

Prognostic factors for the development of lower respiratory tract infection after influenza virus infection in allogeneic hematopoietic stem cell transplantation recipients: A KSGCT Multicenter Analysis.

Y. Kanda, M. Onizuka, Satoshi Takahashi, 2023, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Retrospective analysis of Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic hematopoietic stem cell transplant versus chemotherapy combined with tyrosine kinase inhibitor

Katsuhiro Shono, A. Yokota, M. Onoda, 2015, Leukemia & lymphoma.